| Literature DB >> 27802223 |
Richard McClure1,2,3, Henry Ong1,2, Vaibhab Janve1,2, Shawn Barton1,2, Meiying Zhu1,2, Bo Li1,2, Mary Dawes4, W Gray Jerome5, Adam Anderson1,2,6, Pierre Massion7, John C Gore1,2,6,3, Wellington Pham1,2,6,7,8,3.
Abstract
We report a novel approach for the delivery of curcumin to the brain via inhalation of the aerosol for the potential treatment of Alzheimer's disease. The percentage of plaque fraction in the subiculum and hippocampus reduced significantly when young 5XFAD mice were treated with inhalable curcumin over an extended period of time compared to age-matched nontreated counterparts. Further, treated animals demonstrated remarkably improved overall cognitive function, no registered systemic or pulmonary toxicity associated with inhalable curcumin observed during the course of this work.Entities:
Keywords: Aerosol; amyloid-β; curcumin; nebulization
Mesh:
Substances:
Year: 2017 PMID: 27802223 PMCID: PMC5848215 DOI: 10.3233/JAD-160289
Source DB: PubMed Journal: J Alzheimers Dis ISSN: 1387-2877 Impact factor: 4.472